Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
astrazeneca
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
cancer
glaxosmithkline
pfizer
bristol-myers squibb
celgene
duchenne muscular dystrophy
eli lilly
fda
fibrogen
finch therapeutics
What
bio
roundup
conference
opioid
abbvie’s
acquisitions
annual
ash
august
barbecuing
barcelona
biggest
biotech
build
busy
buy
camping
cancer
cardiologist
center
ceo
check
cholesterol
clinical
company’s
daniel
day
days
debut
december's
decisions
devices
drug
drugs
dyne’s
esmo
european
fda
flop
gilead
Language
unset
4
×
Current search:
astrazeneca
×
unset
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More